Lipoprotein disorder in brain infarction and hemorrhage

Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351.

Stamler J, Wentworth D, Neaton JD, for the MRFIT research group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the multiple risk factor intervention trial (MRFIT). JAMA 1986; 256: 2823.

Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991; 11: 2.

Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler HA. High density lipoprotein cholesterol and cardiovascular disease; four prospective American studies. Circulation 1989; 79: 8.

Tell GS, Crouse JR, Furberg CD. Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis. Stroke 1988; 19: 423.

Fukuzawa T, Torihama Y, Nagashima T, Yamamoto M, Oikawa T, Yamauchi Y, Hirose N, Shigematsu H, Hata Y, Kishi A, Araki G. Serum lipids and apolipoproteins in cerebrovascular disease. J Jpn Atheroscler Soc 1985; 13: 567.

Matsuda M, Miyahara T, Murai A, Fujimoto N, Kameyama M. Lipoprotein abnormalities in survivors of cerebral infarction with a special reference to apolipoproteins and triglyceride-rich lipoproteins. Atherosclerosis 1987; 68: 131.

Salonen JT, Salonen R. Association of serum low density lipoprotein cholesterol, smoking and hypertension with different manifestations of atherosclerosis. Int J Epidemiol 1990; 19: 911.

Adams R, Carroll RM, Nichols FT, McNair N, Feldman DS, Feldman EB, Thompson WO. Plasma lipoproteins in cortical versus lacunar infarction. Stroke 1989; 20: 448.

Pedro-Botet J, Senti M, Nogues X, Rubies-Part J, Roquer J, D’Olhaberriague L, Olive J. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apoprotein E polymorphism. Stroke 1992; 23: 1556.

Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989; 320: 904.

Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 1989; 20: 1460.

Hatch FT, Lees RS. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 1968; 6: 1.

Ryomoto KI, Suzuki M, Tushima M, Yammoto A, Harano Y. Effects of simvastatin on the number and composition of apoprotein B-containing lipoproteins in hypercholesterolemia: analysis of apoprotein B in each lipoprotein fraction by highly sensitive latex method. Endocr J 1996; 43: 469.

Sniderman AD, Malpole DG, Skinner BF, Shapiro S, Teng B, Kwiterovic PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (b) lipoproteins). Proc Natl Acad Sci USA 1980; 77: 604.

Kwiterovich PO Jr. HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease. Clin Chem 1988; 34: B71.

Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovic PO Jr. Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc Natl Acad Sc USA 1983; 80: 6662.

Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917.

Okamura H, Kawada M, Suehiro T, Ohno F. Low density lipoprotein subclass pattern B (small, dense LDL) in patients with cerebral infarction. J Jpn Atheroscler Soc 1991; 19: 1079.

Fukuzawa T. Serum lipids, lipoproteins and apolipoproteins in cerebrovascular disease with particular reference to LDL-size. Jpn J Stroke 1987; 9: 354.

Bamford JM, Warlow CP. Evolution and testing of the lacunar hypothesis. Stroke 1988; 19: 1074.

Millikan C, Futrell N. The fallacy of the lacune hypothesis. Stroke 1990; 21: 1251.

Harano Y, Nakao Y, Kageyama A, Suzuki M, Hirose J, Asakura Y, Sato A, Komatsu R, Tsushima M, Yamamoto A. Contribution of hyperinsulinemia and hyperglycemia to lipoprotein disorder in obesity. In: Oomura Y, Tarui S, Inoue S, Shimizu T, eds. Progress in obesity research 1990. London: Libbey 1990: 299.

Kageyama A, Nakao Y, Hirose Y, Yokota C, Sato A, Suzuki M, Tsushima M, Katayama Y, Harano Y. Abnormalities of ApoB containing lipoprotein particles and macroangiopathy in nonobese NIDDM. J Jpn Diab Soc 1993; 36: 349.

Harano Y, Kageyama A, Nakao Y, Hara Y, Suzuki M, Sato A, Ikebuchi M, Shinozaki K, Tsushima M. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects. Diabetes 1996; 45 [Suppl 3]: S31.

Nakao Y, Kageyama A, Ikeda K, Sato A, Asakura Y, Hirose J, Suzuki M, Tsushima M, Harano Y. Quantitative and qualitative alterations of plasma lipoproteins in obesity. Folia Endocrinol 1993; 69: 670.

Ikeda K, Suzuki M, Ikebuchi M, Hara Y, Tsushima M, Yamamoto A, Harano Y. Hyperapolipobetaproteinemia with small LDL, a characteristic disorder of lipoprotein in essential hypertension. J Diabetes Complications 1995; 9: 227.

Shinozaki K, Naritomi H, Shimizu M, Ikebuchi M, Sawada T, Hrano Y. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 1996; 27: 37.

Nordestgaard BG, Zilversmit DB. Comparison of arterial clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits. Arteriosclerosis 1989; 9: 176.

McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: results of the Framingham offspring study. Arteriosclerosis 1987; 7: 483.

Austin MA, King MC, Vranizan KM, Newman B, Krauss RM. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet 1988; 43: 838.

Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic maker for coronary heart disease risk. Circulation 1990; 82: 495.

Austin MA, Krauss RM. Genetic control of low-density-lipoprotein subclasses. Lancet 1986; II: 592.

Campos B, Brijlevens E, McNamara JR, Ordovas JM, Ponser BM, Wilson PWF, Castelli WP, Scfaefer EJ. LDL particle size distribution: results from the Framingham offspring study. Arterioscler Thromb 1992; 12: 1410.

Karpe F, Tornvall P, Olivecrona T, Steiner G, Carlson LA, Hamsten A. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis 1993; 98: 33.

Campos H, Deron DM, Krauss RM. Variations in hepatic lipase and lipoprotein lipase activities associated with low density lipoprotein subclass patterns (abstract). Circulation 1991; 84 [Suppl II]: II20.

Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 1993; 13: 147.

Teng B, Sniderman AD, Soutar AK, Thompson GR. Metabolic basis of hyperapobetalipoproteinemia, turnover of apoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J Clin Invest 1986; 77: 663.

Alam R, Yatsu FM, Kasturi R, Bui G. Low and high density lipoprotein metabolism in atherothrombotic brain infarction. Stroke 1992; 23: 1265.

Woo J, Lam CWK, Kay R, Wong HY, Teoh R, Nicholls MG. Acute and long-term changes in serum lipids after acute stroke. Stroke 1990; 21: 1407.

Hollanders FD, Shafar J. Serum lipid changes following the completed stroke syndrome. Postgard Med J 1975; 51: 386.

Mendez I, Hachinski V, Wolfe B. Serum lipids after stroke. Neurology 1987; 37: 507.